Endoscopic Vessel Harvesting Systems Market Analysis

Endoscopic Vessel Harvesting Systems Market Analysis

To get key market trends

  Download Free Sample

The market by product type is categorized into EVH systems, endoscopes, and accessories. The EVH systems segment dominates the endoscopic vessel harvesting systems market with a revenue of around USD 302.8 million in 2023.
 

• The demand for EVH systems is driven by the clinical need for minimally invasive techniques in cardiac surgery, particularly for procedures like coronary artery bypass grafting (CABG). Endoscopic vessel harvesting is a critical step in CABG surgery, and EVH systems offer increased advantages compared to traditional open harvesting methods. This clinical need is anticipated to fuel the demand for EVH systems in the cardiac surgery setting. 
   
• Moreover, EVH systems are specifically designed for the harvesting of blood vessels in cardiac surgery, providing surgeons with dedicated tools and features tailored to this procedure. In contrast, endoscopes and accessories may have a broader range of applications across various medical specialties, making EVH systems more specialized and in-demand for their specific purpose.
   

The endoscopic vessel harvesting systems market by usability is categorized into reusable and disposable. The reusable segment dominates the market with a revenue of around USD 354.7 million in 2023.
 

• The cost for reusable EVH systems typically tends to be lower as they can be sterilized and reused multiple times. Healthcare facilities with high procedural volumes may find reusable systems more cost-effective in the long run, leading to greater demand for this segment.  
   
• Moreover, reusable EVH systems may offer greater flexibility and customization options which allows healthcare facilities to choose compatible instruments and accessories. This flexibility allows for greater efficiency and optimization of the vessel harvesting process, contributing to the demand for reusable systems.
   

The endoscopic vessel harvesting systems market by technique is categorized into open tunnel harvesting and closed tunnel harvesting. The closed tunnel harvesting segment dominates the market with a revenue of around USD 328.8 million in 2023.
 

• Studies have demonstrated reduced risks of wound infection, hematoma formation, and nerve injury with closed tunnel harvesting, contributing to its increasing adoption. The potential for fewer complications enhances the safety profile of closed tunnel harvesting and drives its demand among surgeons and healthcare facilities.
   
• Moreover, closed tunnel harvesting typically results in smaller incisions and less visible scarring. These improved cosmetic outcomes associated with closed tunnel harvesting appeal to patients, particularly those concerned about aesthetic considerations. Surgeons may also prefer closed tunnel harvesting for its ability to achieve better cosmesis, contributing to its increasing demand.
   

The endoscopic vessel harvesting systems market by vessel type is categorized into saphenous vein, radial artery, and internal mammary artery. The saphenous vein segment held a majority market share and was valued at around USD 304 million in 2023.
 

• The saphenous vein is one of the most commonly used conduits for CABG surgery, which involves bypassing blocked or narrowed coronary arteries to restore blood flow to the heart muscle. As CABG procedures remain a mainstay in the treatment of coronary artery disease, there is a consistent demand for saphenous vein harvesting systems.
   
• The saphenous vein is readily accessible and can be easily harvested from the patient's leg. Compared to other potential graft sources, the saphenous vein is often more accessible and can be harvested with fewer technical challenges. This ease of access contributes to the widespread use of saphenous vein systems in CABG surgery and drives the demand for harvesting systems specifically designed for this vessel type.
   

The endoscopic vessel harvesting systems market by application is categorized into coronary artery disease and peripheral artery disease. The coronary artery disease segment is anticipated to reach around USD 531 million by 2032.
 

• Increased healthcare spending and improved access to medical care have led to better detection, diagnosis, and management of CAD. Advances in medical technology and diagnostic techniques enable earlier detection of CAD, allowing for timely interventions to prevent disease progression and reduce complications.
   
• Additionally, CAD is one of the leading causes of deaths globally and has been on the rise due to certain lifestyle related factors. The aging population, in particular, contributes to a higher prevalence of CAD, as the risk of developing the disease increases with age, and is contributing to the rising demand for endoscopic vessel harvesting systems for CAD applications.
   

The endoscopic vessel harvesting systems market by end-use is categorized into hospitals, ambulatory surgical centers, and other end-users. The hospital segment held a majority market share in with a revenue of around USD 325.4 million in 2023.
 

• Endoscopic vessel harvesting systems are primarily used in cardiac surgery, specifically for procedures like coronary artery bypass grafting (CABG). These surgeries are complex and require specialized equipment and expertise, which are typically found in hospital settings with dedicated cardiac surgery departments, making them most prominent end user for these devices.
   
• Moreover, cardiac surgery requires highly skilled and experienced surgical teams, including cardiothoracic surgeons, anesthesiologists, perfusionists, and operating room nurses. Hospitals employ specialized cardiac surgery teams with expertise in using EVH systems to perform complex procedures safely and effectively. Hence, they are the major facilities to utilize and incorporate these devices.
   

North America endoscopic vessel harvesting systems market accounted for USD 222.7 million in revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
 

• North America has a significant burden of cardiovascular diseases (CVDs), including coronary artery disease (CAD) and peripheral artery disease (PAD). As such, there is a considerable demand for effective treatment options, including CABG surgeries where endoscopic vessel harvesting systems are utilized. Further, continuous advancements in endoscopic vessel harvesting systems, such as the development of minimally invasive techniques and robotic-assisted procedures, contribute to the demand for these systems in the region.
   
• Moreover, favorable reimbursement policies for minimally invasive surgical procedures, including EVH, incentivize healthcare providers to adopt these technologies. In North America, robust healthcare systems and adequate reimbursement for cardiac surgeries contribute to the widespread adoption of EVH systems in hospitals and surgical centers.